XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.3
SHAREHOLDERS' EQUITY - Narrative (Details)
3 Months Ended 6 Months Ended 67 Months Ended
Jul. 18, 2021
Feb. 04, 2020
USD ($)
sales_agent
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
May 21, 2024
USD ($)
May 20, 2024
USD ($)
Aug. 02, 2022
USD ($)
Aug. 01, 2022
USD ($)
Aug. 31, 2021
USD ($)
Jul. 28, 2021
USD ($)
May 26, 2021
USD ($)
Feb. 20, 2020
Mar. 04, 2019
USD ($)
Subsidiary or Equity Method Investee [Line Items]                                
Repurchase authorized amount                       $ 20,000,000 $ 20,000,000      
Restricted Stock | 2010 Plan                                
Subsidiary or Equity Method Investee [Line Items]                                
Right to grant period 10 years                              
Equity ATM Program                                
Subsidiary or Equity Method Investee [Line Items]                                
Maximum consideration threshold   $ 100,000,000.0           $ 1,000,000,000 $ 650,000,000 $ 650,000,000.0 $ 250,000,000.0     $ 250,000,000.0   $ 50,000,000.0
Number of additional sales agents | sales_agent   2                            
Gross sales commission percentage                           1.50% 2.00%  
Number of shares sold (in shares) | shares     839,099 1,100,000 2,338,080 3,627,458 27,684,517                  
Weighted average price per share (in usd per share) | $ / shares     $ 24.49 $ 20.77 $ 25.20 $ 18.86 $ 21.23                  
Gross proceeds received     $ 20,552,000 $ 22,844,000 $ 58,920,000 $ 68,416,000 $ 587,800,000                  
Net proceeds received     20,244,000 $ 22,501,000 58,036,000 $ 67,390,000 578,600,000                  
Available under the equity ATM program     $ 412,200,000   $ 412,200,000   $ 412,200,000